227 results on '"Pemp, Berthold"'
Search Results
2. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – a comprehensive assessment of patient satisfaction
3. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study
4. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – an assessment of sick leave, presenteeism, and health care utilization
5. The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI – an external validation study
6. The Vienna idiopathic intracranial hypertension database—An Austrian registry
7. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
8. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial
9. Retinal Layer Thinning for Monitoring Disease-modifying Treatment in Relapsing Multiple Sclerosis—Evidence for Applying a Rebaselining Concept (P6-6.005)
10. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – a comprehensive assessment of patient satisfaction
11. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – an assessment of sick leave, presenteeism, and health care utilization
12. A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin
13. Plasma Calcitonin Gene-Related Peptide Levels in Idiopathic Intracranial Hypertension: An Exploratory Study
14. Associations of neurovascular dysfunction with inner retinal layer thickness in non‐proliferative diabetic retinopathy
15. Vertikale Blickparesen bei dorsalem Mittelhirnsyndrom und anderen Erkrankungen
16. Visual function in chronic Leber’s hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset
17. The Vienna idiopathic intracranial hypertension database—An Austrian registry
18. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome
19. Impact of rater experience and referral question on detecting MRI features of idiopathic intracranial hypertension
20. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
21. Addition of optic nerve involvement to dissemination in space criteria for multiple sclerosis – the value of optical coherence tomography (S46.009)
22. Impact of rater experience and referral question on detecting magnetic resonance imaging features of idiopathic intracranial hypertension.
23. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes
24. Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis
25. Impact of rater experience on detecting MRI features of idiopathic intracranial hypertension
26. Additional file 1 of Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
27. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
28. Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis
29. Correlations between visual function and inner retinal structure in OPA1 autosomal dominant optic atrophy
30. NCMP-10. NEURO-OPHTHALMOLOGICAL FINDINGS IN CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA - A RETROSPECTIVE ANALYSIS
31. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcome
32. Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone
33. The Vienna Idiopathic Intracranial Hypertension (VIIH) database – an Austrian registry
34. Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis.
35. Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
36. Magnetic Resonance Imaging Signs of Idiopathic Intracranial Hypertension.
37. NF1 optic pathway glioma. Analysing risk factors for visual outcome and indications to treat
38. 8. RETINAL AND RETROBULBAR HEMODYNAMIC CHANGES AFTER INTRAVITREAL ANTI-VEGF TREATMENT IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: WHAT ARE THE EFFECTS ON CLINICAL OUTCOME AT 1 YEAR?: 0508
39. Effectiveness of averaging strategies to reduce variance in retinal nerve fibre layer thickness measurements using spectral-domain optical coherence tomography
40. Effects of orally administered moxaverine on ocular blood flow in healthy subjects
41. Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance
42. Ocular blood flow in diabetes and age-related macular degeneration
43. Strategies for reducing variance in laser Doppler flowmetry measurements
44. Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
45. Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
46. Changes in Visual Function and Correlations with Inner Retinal Structure in Acute and Chronic Leber’s Hereditary Optic Neuropathy Patients after Treatment with Idebenone
47. Calculation of central retinal artery diameters from non-invasive ocular haemodynamic measurements in type 1 diabetes patients
48. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects – a study using spectral fundus reflectance
49. The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects
50. Retinal layer thinning rate as a biomarker predicting treatment response in relapsing multiple sclerosis (307)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.